Skip to main content
. Author manuscript; available in PMC: 2015 Jan 6.
Published in final edited form as: Inorg Chem. 2013 Dec 20;53(1):167–181. doi: 10.1021/ic4019585

Table 2.

X-ray crystallographic data for compounds 7-12 (Chart 1) at 100 Ka

Compounds 7·3DMF·Et2O 8·2DMF 9·2DMF 10·4MeCN 11·DMF 12·2DMF
Formula C105H150B4
F16Fe5
N25O13
C92H116B2
F8Fe4
N22O9
C92H112B2
F8Fe4N22O8
C51H62B2
F8Fe
N14O
C48H60B2
F8Fe2
N12O3
C55H78B3
F12Fe2
N14O7
formula weight 2596.99 2071.09 2051.06 1116.62 1138.40 1419.44
crystal system triclinic triclinic triclinic orthorhombic monoclinic Triclinic
space group Pbcn P21/n
a, Å 17.548(2) 15.092(2) 17.282(1) 23.978(2) 13.879(1) 12.821(4)
b, Å 18.524(2) 17.612(3) 17.599(1) 11.555(8) 23.342(2) 17.528(6)
c, Å 20.896(2) 27.955(4) 23.455(3) 19.580(1) 15.968(1) 17.703(6)
α, deg 78.952(2) 85.993(3) 100.636(2) 73.288 (1)
β, deg 71.109(2) 80.605(2) 95.959(2) 97.122(2) 76.650(1)
γ, deg 69.479(2) 64.731(2) 116.188(1) 79.532(1)
V, Å3 5995.2(1) 6629.1(2) 6151.0(1) 5425.0(6) 5133.0(8) 3678.9(2)
Z 2 2 2 4 4 2
ρcalcd, gm/cm3 1.439 1.257 1.107 1.367 1.473 1.281
μ, mm−1 0.684 0.506 0.527 0.357 0.649 0.478
θ range, deg 1.63-25.76 1.48-25.80 1.61-24.75 1.70-25.71 1.55-25.69 1.49-25.70
completeness to θ
, %
99.1 99.0 98.6 100.0 100.0 99.8
reflections
collected
95976 25264 92034 84107 83460 58867
independent
reflections
22796 107121 20801 5165 9751 13988
R(int) 0.0585 0.0630 0.0457 0.0422 0.0469 0.0365
drestraints 16 6 3 3 46 17
Parameters 1509 1269 1161 360 668 791
max., min.
transmission
0.9731, 0.8210 0.9899,
0.8629
0.9691,
0.8169
0.9858, 0.9385 0.9745,
0.9262
0.9811,
0.9104
R1b(wR2)c
[I>2sigma(I)]
0.0841
(0.2271)
0.0809
(0.2559)
0.0762
(0.2433)
0.0652
(0.1622)
0.0912
(0.2200)
0.0848
(0.2554)
R1b(wR2)c 0.1140
(0.2484)
0.1157(0.278
9)
0.0959
(0.2587)
0.0776
(0.1737)
0.1089
(0.2335)
0.1110
(0.2771)
GOF(F2)d 1.073 1.116 1.096 1.057 1.051 1.143
emax, min peaks,
e.Å−3
1.821
, −1.137
1.096, −0.675 1.118, −1.136 1.467,
−0.951
1.232,
−1.101
1.473,
−1.418
a

Mo Kα radiation (λ = 0.71073 Å).

b

R1 = Σ∥Fo∣-∣Fc∥/Σ∣Fo∣.

c

wR2 = {Σ[w(Fo2-Fc2)2]/Σ[w(Fo2)2]}1/2.

c

GOF = {Σ[w(Fo2–Fc2)2]/(n–p)}1/2, where n is the number of data and p is the number of refined parameters.

d

7, disordered DMF (2), diethyl ether (1); 8, disordered DMF (2), N-Et group (2); 9, disordered DMF(1), N-Et group (1); 10, MeCN (3); 11, disordered DMF (1), BF4 (2), N-Et (2), N-CH (4); 12, disordered DMF (1), perchlorate (3).

e

7, near one BF4, disorder modeling was not reasonable; 8, near iron; 9, near BF4, disorder modeling was not helpful; 10, near alkoxide group, not taken into account; 11, near severely disordered benzimidazole; 12, near hydroxide groups, no meaningful disorder modeling found; 13, near one of the perchlorates, disorder modeling was not helpful.